Skip to main content
. 2021 Jun 24;92(6):753–759. doi: 10.1080/17453674.2021.1941624

Table 1.

Summary of clinical, serological, pathological and molecular data

Case
no.
Sex Age Swelling
(days)
CRP
(< 5 mg/L)
WBC count
(< 11.3 G/L)
Biopsy Histology Serologic
testing
PCR Culture
1 m 26 38 0.6 4.8 IB Granulomatous inflammation with necrosis n.a. pos neg
2 m 16 29 21.9 11.2 n.d. n.a. 1:256 n.a. n.a.
3 f 22 28 0.6 6.6 n.d. n.a. 1:64 n.a. n.a.
4 m 36 42 2.1 5.1 EB Granulomatous inflammation with necrosis n.a. pos neg
5 f 12 23 1.0 7.6 n.d. n.a. 1:256 n.a. n.a.
6 f 26 17 1.1 6.3 CNB Granulomatous inflammation with necrosis n.a. pos neg
7 f 40 33 n.a. n.a. n.d. n.a. 1:64 n.a. n.a.
8 f 27 21 16.9 7.7 EB Granulomatous inflammation with necrosis 1:256 pos neg
9 m 74 150 3.6 6.2 CNB, Granulomatous inflammation with necrosis, n.a. pos neg
            IB, EB metastasis of malignant melanoma      
10 f 37 270 n.a. n.a. EB Granulomatous inflammation with necrosis n.a. pos n.a.

Legend: CNB: core-needle biopsy; CRP: C-reactive protein; EB: excision biopsy; IB: incision biopsy; n.a.: not available; n.d.: not done; neg: negative; PCR: polymerase chain reaction; pos: positive; WBC: white blood cell.